Table 2.
Parameter | Hazard ratio | Lower 95% CL | Upper 95% CL | Pr > |t| |
---|---|---|---|---|
OS (n = 212) | ||||
Age | 1.041 | 1.023 | 1.059 | <.001 |
Sex | 1.349 | 0.784 | 2.321 | .280 |
Stage | 1.094 | 0.578 | 2.073 | .782 |
Histology | 1.355 | 0.753 | 2.439 | .311 |
CD15 negativity | 1.641 | 0.879 | 3.062 | .120 |
TCA status | 3.320 | 1.611 | 6.842 | .001 |
EFS (n = 213) | ||||
Age | 1.019 | 1.005 | 11.032 | .006 |
Sex | 1.411 | 0.917 | 2.172 | .118 |
Stage | 1.541 | 0.963 | 2.467 | .072 |
Histology | 1.263 | 0.799 | 1.995 | .317 |
CD15 negativity | 1.120 | 0.673 | 1.862 | .663 |
TCA status | 2.556 | 1.455 | 4.490 | .001 |
Only age and TCA status were independently associated with outcome in both OS and EFS analyses.
CL, confidence limit.